期刊文献+

生长抑素十四肽和八肽对门脉高压症患者肝内门体分流术后门静脉血流动力学的影响 被引量:13

Effects of Somatostatin-14 and-8 on portal hemodynamics in patients with portal hypertension after intrahepatic portosystemic shunt
暂未订购
导出
摘要 目的:研究生长抑素十四肽和八肽对门脉高压症患者门静脉血流动力学的影响和外周静脉血中胰岛素样生长因子(IGF-1)、血管内皮素(ET-1)、胰高血糖素(GLU)、一氧化氮(NO)浓度变化。方法:采用两交叉设计对14例门脉高压症经颈内静脉肝内门体分流术(TIPS)后患者经颈内静脉留置于门静脉内支架下方的导管,直接测静脉压,动态观察门静脉血流动力学改变,同时检测IGF-1、ET-1、GLU、NO血浆浓度。生长抑素十四肽(6 mg/d)、生长抑素八肽(0.6mg/d)分别于TIPS术后24 h采用微量泵持续24 h经周围静脉输注。用药前及用药后8、24 h进行检测。结果:生长抑素十四肽和八肽用药前后门静脉压力最大差值分别为(9.4±1.0)cmH2O和(5.0±1.0)cmH2O,两者用药前后比较有非常显著性差异(P<0.01),生长抑素十四肽与八肽两者比较有非常显著性差异(P<0.01)。IGF-1、GLU用药前后比较有显著性差异(P<0.05)。NO、ET-1用药前后比较无显著性差异(P>0.05)。结论:生长抑素十四肽(6mg/d)、生长抑素八肽(0.6mg/d)均有降低门静脉压力的作用,但生长抑素十四肽的降压作用更为显著。两者用药后显著降低血中IGF-1、GLU浓度。其作用机制可能是通过降低血中IGF-1、GLU等激素的分泌和释放,降低肝的代谢,减少肝血流量,从而降低门静脉压力。 Objective:To study the effects of Somatostatin-14 and -8 on portal hemodynamics and plasma levels of the insulin-like growth factor ( IGF-1 ), nitric oxide ( NO), endothelin-1 ( ET-1 ) and glucagon (GLU) in patients with portal hypertension after transjugular intrahepatic portosystemic shunt (TIPS). Methods: Fourteen portal hypertension patients underwent TIPS, their portal pressures directly measured by the intravenous catheter placed in the portal vein, the hemodynamic changes observed and the plasma levels of IGF-1, NO, ET-1 and GLU determined before and 8 and 24 hours after the infusion of Somatostatin-14 or -8 according to a cross-over design. Results :The average decrease in portal pressure after the intravenous infusion of Somatostatin-14 and -8 was (9.4 ±1.0 ) cmH20 and (5.0 ± 1.0 ) cmH2O, respectively (P 〈 0.01 ), with significant differences before and after the infusion as well as between the Somatostatin-14 and -8 groups ( P 〈 0.01 ). Significant reduction was observed in GLU and IGF-1 (P 〈 0.05 ), but not in NO and ET-1 ( P 〉 0.05 ) 8 and 24 hours after the infusion. Conclusion :Both Somatostatin-14 and -8 can significantly reduce portal pressure, although the former is more potent than the latter. The underlying mechanism may involve their inhibition of the secretion of GLU, IGF-1 and other hormones as well as their reduction of hepatic metabolism and portal inflow.
出处 《医学研究生学报》 CAS 2007年第11期1186-1188,共3页 Journal of Medical Postgraduates
基金 江苏省自然科学基金创新人才项目(批准号:BK2005432) 南京军区南京总医院科研基金资助项目(批准号:2005050)
关键词 门脉高压症 生长抑素 血流动力学 Portal hypertension Somatostatin Hemodynamics
  • 相关文献

参考文献7

  • 1Gupta TK, Toruner M, Chung MK, et al. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic micro-circulation of cirrhotic rats [ J ]. Hepatology, 1998, 28 ( 4 ) : 926- 931.
  • 2Rockey DC, Chung JJ. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension [ J ]. Gastroenterology, 1998,114 ( 2 ) : 344-351.
  • 3Chatila R, Ferayomi L, Gupta T, et al. Local arterial vasoconstriction induced by octreotide in patients with cirrhosis [ J]. Hepatology, 2000, 31(3): 572-576.
  • 4Jones JI, Clemmons DR. Insulin-like growth factor and their binding proteins: biological actors [ J ]. Endocr Rev, 1995,16 ( 1 ) : 3-34.
  • 5Castilla-Cortazar I,Aliaga-Montilla MA ,Salvador J, et al. Insulin- like growth factor-1 restores the reduced somatostatinergic tone controlling growth hormone secretion in cirrhotic rats [ J]. Liver, 2001,21 (6) :405-409.
  • 6范海健,王勇,吴效科.胰岛素样生长因子系统的研究进展[J].医学研究生学报,2005,18(8):746-750. 被引量:21
  • 7Sabat M, Guarner C, Sofiano G, et al. Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites [ J ]. Dig Dis Sci, 1998,43(10) : 2184-2189.

二级参考文献22

  • 1万芳,钟刚,何福仙,陈敏,关艳梅.ERK/MAPK信号通路激活与乳腺癌细胞浸润性生长的关系[J].医学研究生学报,2004,17(6):490-492. 被引量:17
  • 2孟庆欣,王炼,吴效科,杨斌.经直肠彩色多普勒超声对多囊卵巢综合征卵巢间质内血流动力学的研究[J].医学研究生学报,2005,18(2):132-134. 被引量:14
  • 3黄文斌,周晓军.胰岛素样生长因子结合蛋白在人类恶性肿瘤中的研究进展[J].医学研究生学报,2005,18(2):156-160. 被引量:11
  • 4Pawelczyk L, Spaczynski RZ, Banaszewska B,et al. Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome[J]. Eur J Obstet Gynecol Reprod Biol, 2004 ,113(2):209-213.
  • 5Belli SH, Graffigna MN, Oneto A,et al.Effect of rosiglitazone on insulin resistance,growth factors,and reproductive disturbances in women with polycystic ovary syndrome[J]. Fertil Steril, 2004,81(3):624-629.
  • 6Kaytor EN, Zhu JL, Pao CI,et al. Insulin-responsive nuclear proteins facilitate Sp1 interactions with the insulin-like growth factor-Ⅰ gene[J]. Biol Chem, 2001, 276(40):36896-36901.
  • 7Brink M, Chrast J, Price SR,et al. Angiotensin Ⅱ stimulates gene expresssion of cardiac insulin-like growth factor Ⅰ and its receptor through effects on blood pressure and food intake[J].Hypertension, 1999,34(5):1053-1059.
  • 8Wang J, Zhou J, Powell-braxton L,et al. Effects of Igfl gene delection on postnatal growth patterns[J].Endocrinology, 1999,140(7):3391-3394.
  • 9Winnay JN,Bruning JC,Burks DJ,et al.Gab-1-mediated IGF-Ⅰ signaling in IRS-1-deficient 3T3 fibroblasts[J].Biol Chem, 2000,275(14):10545-10550.
  • 10Ravichandran LV, Chen H, Li Y,et al. Phosphorylation of PTP1B at Ser(50) by Akt impairs its ability to dephosphorylate the insulin receptor[J].Mol Endocrinol, 2001,15(10):1768-1780.

共引文献20

同被引文献92

引证文献13

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部